TNFRSF8 and anaplastic large cell lymphoma: The WHO classification distinguishes ALK‐positive ALCL, ALK‐negative ALCL, breast implant‐associated ALCL and cutaneous CD30‐positive lymphoproliferations (cutaneous ALCL and lymphomatoid papulosis).3